|
WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
EP4541818A3
(en)
|
2012-05-25 |
2025-07-23 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
|
US11077144B2
(en)
|
2013-05-13 |
2021-08-03 |
Cellectis |
CD19 specific chimeric antigen receptor and uses thereof
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
WO2015092024A2
(en)
*
|
2013-12-20 |
2015-06-25 |
Cellectis |
Method of engineering multi-input signal sensitive t cell for immunotherapy
|
|
US10189908B2
(en)
|
2014-02-05 |
2019-01-29 |
The University Of Chicago |
Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants
|
|
GB201405845D0
(en)
|
2014-04-01 |
2014-05-14 |
Ucl Business Plc |
Signalling system
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
GB201415347D0
(en)
|
2014-08-29 |
2014-10-15 |
Ucl Business Plc |
Signalling system
|
|
WO2016062898A1
(en)
*
|
2014-10-24 |
2016-04-28 |
Bcrt Holding Bv |
T cell-based immunotherapeutics
|
|
JP2018504104A
(ja)
*
|
2014-12-17 |
2018-02-15 |
セレクティスＣｅｌｌｅｃｔｉｓ |
非Ｔ細胞伝達ドメインを発現する阻害性キメラ抗原受容体（ｉＣＡＲまたはＮ−ＣＡＲ）
|
|
IL301458A
(en)
|
2014-12-24 |
2023-05-01 |
Autolus Ltd |
A cell that simultaneously expresses a chimeric antigen receptor (CAR) of 19CD and 22CD
|
|
JP7264592B2
(ja)
|
2015-01-26 |
2023-04-25 |
ザ ユニバーシティー オブ シカゴ |
ＩＬ１３Ｒα２結合剤及び癌治療におけるその使用
|
|
EP3250611B1
(en)
|
2015-01-26 |
2021-04-21 |
The University of Chicago |
Car t-cells recognizing cancer-specific il 13r-alpha2
|
|
WO2016120218A1
(en)
|
2015-01-26 |
2016-08-04 |
Cellectis |
ANTI-CLL1 SPECIFIC SINGLE-CHAIN CHIMERIC ANTIGEN RECEPTORS (scCARS) FOR CANCER IMMUNOTHERAPY
|
|
EP3261651B1
(en)
*
|
2015-02-27 |
2022-05-04 |
iCell Gene Therapeutics LLC |
Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof
|
|
GB201503742D0
(en)
|
2015-03-05 |
2015-04-22 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
TWI700298B
(zh)
|
2015-04-13 |
2020-08-01 |
美商輝瑞股份有限公司 |
靶向ｂ細胞成熟抗原之嵌合型抗原受體類
|
|
GB201507115D0
(en)
*
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic Acid Construct
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
BR112017024757A2
(pt)
|
2015-05-18 |
2018-11-13 |
TCR2 Therapeutics Inc. |
composições e métodos para reprogramação de tcr utilizando proteínas de fusão
|
|
CN104829733B
(zh)
*
|
2015-05-25 |
2018-06-05 |
广州百暨基因科技有限公司 |
抗原结合单元稳定的嵌合抗原受体及制备方法与应用
|
|
US11173179B2
(en)
|
2015-06-25 |
2021-11-16 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
|
|
TW202444897A
(zh)
|
2015-06-25 |
2024-11-16 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體(car)、組合物及其使用方法
|
|
EP3317399B1
(en)
*
|
2015-06-30 |
2024-06-26 |
Cellectis |
Methods for improving functionality in nk cell by gene inactivation using specific endonuclease
|
|
MX2018001776A
(es)
|
2015-08-11 |
2018-06-06 |
Cellectis |
Celulas para inmunoterapia modificadas geneticamente para dirigirse al antigeno cd38 y para la inactivacion del gen cd38.
|
|
KR102739782B1
(ko)
*
|
2015-09-11 |
2024-12-09 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
생물학적으로 관련된 직교 사이토카인/수용체 쌍
|
|
PH12018500645B1
(en)
|
2015-09-24 |
2022-10-21 |
Abvitro Llc |
Hiv antibody compositions and methods of use
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
WO2017075537A1
(en)
|
2015-10-30 |
2017-05-04 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
CN108472365A
(zh)
|
2015-10-30 |
2018-08-31 |
艾丽塔生物治疗剂公司 |
用于肿瘤转导的组合物和方法
|
|
GB201519900D0
(en)
*
|
2015-11-11 |
2015-12-23 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
EP3405481B1
(en)
|
2016-01-21 |
2023-01-18 |
Pfizer Inc. |
Chimeric antigen receptors targeting epidermal growth factor receptor variant iii
|
|
CN107298715B
(zh)
|
2016-04-15 |
2021-05-04 |
阿思科力(苏州)生物科技有限公司 |
Slit2D2-嵌合抗原受体及其应用
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
CN109503721B
(zh)
*
|
2016-05-31 |
2023-03-07 |
上海恒润达生生物科技股份有限公司 |
靶向cd19的嵌合抗原受体及其用途
|
|
JP7114490B2
(ja)
*
|
2016-06-24 |
2022-08-08 |
アイセル・ジーン・セラピューティクス・エルエルシー |
キメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
|
|
CA3031289A1
(en)
*
|
2016-07-18 |
2018-01-25 |
Helix Biopharma Corp. |
Car immune cells to treat cancer
|
|
WO2018026953A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
KR20250103795A
(ko)
|
2016-08-03 |
2025-07-07 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
WO2018045034A1
(en)
*
|
2016-08-30 |
2018-03-08 |
Promab Biotechnologies, Inc. |
Chimeric antigen receptors having gitr intracellular domain as co-stimulatory domain
|
|
MA46236A
(fr)
|
2016-09-14 |
2019-07-24 |
Janssen Biotech Inc |
Récepteurs antigéniques chimériques comprenant des domaines de la fibronectine de type iii spécifiques du bcma, et utilisations correspondantes
|
|
WO2018058432A1
(zh)
*
|
2016-09-28 |
2018-04-05 |
李华顺 |
一种多基因重组嵌合抗原受体分子及其应用
|
|
MX2019003899A
(es)
|
2016-10-07 |
2019-08-14 |
Tcr2 Therapeutics Inc |
Composiciones y metodos para reprogramacion de receptores de linfocitos t mediante el uso de proteinas de fusion.
|
|
EP3525804A4
(en)
*
|
2016-10-11 |
2020-09-09 |
Minerva Biotechnologies Corporation |
HUMANIZED ANTI-MUC1 * ANTIBODIES AND USE OF THE CLIVING ENZYME
|
|
SG11201903089RA
(en)
|
2016-10-14 |
2019-05-30 |
Harvard College |
Aav delivery of nucleobase editors
|
|
AU2017363311A1
(en)
|
2016-11-22 |
2019-06-13 |
TCR2 Therapeutics Inc. |
Compositions and methods for TCR reprogramming using fusion proteins
|
|
US11440958B2
(en)
|
2016-11-22 |
2022-09-13 |
National University Of Singapore |
Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
EP3592381A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
EP3592854A1
(en)
|
2017-04-13 |
2020-01-15 |
Cellectis |
New sequence specific reagents targeting ccr5 in primary hematopoietic cells
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
PE20241587A1
(es)
|
2017-06-02 |
2024-08-01 |
Pfizer |
Receptores de antigenos quimericos que se dirigen a flt3
|
|
JP2020524512A
(ja)
|
2017-06-21 |
2020-08-20 |
アイセル・ジーン・セラピューティクス・エルエルシー |
キメラ抗体受容体（ＣＡＲｓ）の組成物およびその使用方法
|
|
CA3067914A1
(en)
|
2017-06-30 |
2019-01-03 |
Cellectis |
Cellular immunotherapy for repetitive administration
|
|
JP7280238B2
(ja)
|
2017-07-17 |
2023-05-23 |
ヤンセン バイオテツク，インコーポレーテツド |
フィブロネクチンｉｉｉ型ドメインに対する抗原結合領域及びその使用方法
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
SG11202003849VA
(en)
*
|
2017-10-31 |
2020-05-28 |
Allogene Therapeutics Inc |
Methods and compositions for dosing of allogeneic chimeric antigen receptor t cells
|
|
CA3079096A1
(en)
|
2017-11-01 |
2019-05-09 |
Allogene Therapeutics, Inc. |
Modified caspase-9 polypeptides and methods of use thereof
|
|
WO2019106163A1
(en)
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
KR102136063B1
(ko)
|
2017-12-06 |
2020-07-22 |
앱클론(주) |
악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항체 수용체 및 이의 용도
|
|
WO2019118949A1
(en)
|
2017-12-15 |
2019-06-20 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
CN111683971A
(zh)
*
|
2017-12-23 |
2020-09-18 |
宇越生医科技股份有限公司 |
医药重组受体组成物及方法
|
|
TW201936633A
(zh)
|
2018-02-01 |
2019-09-16 |
美商輝瑞大藥廠 |
標靶至cd70的嵌合抗原受體
|
|
TWI878213B
(zh)
|
2018-02-01 |
2025-04-01 |
美商輝瑞大藥廠 |
對cd70具特異性抗體及其用途
|
|
WO2019166946A1
(en)
|
2018-02-28 |
2019-09-06 |
Pfizer Inc. |
Il-15 variants and uses thereof
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
EP3820495A4
(en)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
|
|
US20220177573A1
(en)
*
|
2018-07-09 |
2022-06-09 |
Oslo Universitetssykehus Hf |
Two chimeric antigen receptors specifically binding cd19 and igkappa
|
|
AU2019327913A1
(en)
|
2018-08-29 |
2021-03-18 |
Nanjing Legend Biotech Co., Ltd. |
Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof
|
|
EP3850088A4
(en)
|
2018-09-07 |
2023-07-19 |
Beam Therapeutics, Inc. |
Compositions and methods for improving base editing
|
|
AU2019336245B2
(en)
|
2018-09-07 |
2026-02-26 |
Beam Therapeutics Inc. |
Compositions and methods for delivering a nucleobase editing system
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR THE TREATMENT OF CANCER
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
CA3116412A1
(en)
|
2018-10-31 |
2020-05-07 |
Humanigen, Inc. |
Materials and methods for treating cancer
|
|
US20200268797A1
(en)
|
2018-11-30 |
2020-08-27 |
Janssen Biotech, Inc. |
Gamma delta t cells and uses thereof
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
CN114040977B
(zh)
|
2019-01-31 |
2024-09-03 |
比姆医疗股份有限公司 |
非靶脱氨反应减低的核碱基编辑器和用于定性核碱基编辑器的测定
|
|
SG11202108346WA
(en)
|
2019-02-13 |
2021-08-30 |
Beam Therapeutics Inc |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
AU2020223314A1
(en)
|
2019-02-13 |
2021-08-12 |
Beam Therapeutics Inc. |
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
RU2742000C2
(ru)
*
|
2019-03-13 |
2021-02-01 |
Общество С Ограниченной Ответственностью "Анабион" |
Выделенный альтернативный внутриклеточный сигнальный домен химерного антигенного рецептора и включающий его химерный антигенный рецептор
|
|
EP3942043A2
(en)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
MX2021012726A
(es)
|
2019-04-19 |
2021-11-17 |
Allogene Therapeutics Inc |
Anticuerpos contra receptores de antigenos quimericos derivados de 4g7.
|
|
EP3959235B1
(en)
|
2019-04-26 |
2023-07-26 |
Allogene Therapeutics, Inc. |
Rituximab-resistant chimeric antigen receptors and uses thereof
|
|
CA3152272A1
(en)
|
2019-08-27 |
2021-03-04 |
Janssen Biotech, Inc. |
Chimeric antigen receptor system and uses thereof
|
|
CN115279398B
(zh)
|
2019-09-27 |
2025-07-04 |
比姆医疗股份有限公司 |
治疗液态癌症的组合物和方法
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
CN112079934B
(zh)
*
|
2019-12-17 |
2021-01-29 |
合源生物科技(天津)有限公司 |
一种靶向cd19的嵌合抗原受体及其用途
|
|
WO2021176373A1
(en)
|
2020-03-03 |
2021-09-10 |
Janssen Biotech, Inc. |
ꝩδ T CELLS AND USES THEREOF
|
|
AU2021357520A1
(en)
|
2020-03-05 |
2022-09-29 |
Neotx Therapeutics Ltd. |
Methods and compositions for treating cancer with immune cells
|
|
BR112022022603A2
(pt)
|
2020-05-08 |
2023-01-17 |
Broad Inst Inc |
Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
|
|
AU2021312871A1
(en)
|
2020-07-21 |
2023-02-09 |
Allogene Therapeutics, Inc. |
Chimeric antigen receptors with enhanced signaling and activities and uses thereof
|
|
WO2022031597A1
(en)
|
2020-08-03 |
2022-02-10 |
Kyverna Therapeutics, Inc. |
Methods of producing t regulatory cells, methods of transducing t cells, and uses of the same
|
|
EP4196231A1
(en)
|
2020-08-14 |
2023-06-21 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Chimeric antigen receptor t cells for treating autoimmunity
|
|
CN111944850B
(zh)
*
|
2020-08-28 |
2023-03-31 |
澳门大学 |
表达抗cd22嵌合抗原受体和pd-l1阻断蛋白的细胞的制备方法、表达载体及应用
|
|
US12576151B2
(en)
|
2020-09-25 |
2026-03-17 |
Beam Therapeutics Inc. |
Fratricide resistant modified immune cells and methods of using the same
|
|
JP2024500847A
(ja)
|
2020-12-18 |
2024-01-10 |
センチュリー セラピューティクス，インコーポレイテッド |
適合可能な受容体特異性を有するキメラ抗原受容体システム
|
|
WO2022165419A1
(en)
|
2021-02-01 |
2022-08-04 |
Kyverna Therapeutics, Inc. |
Methods for increasing t-cell function
|
|
KR20230153529A
(ko)
*
|
2021-02-19 |
2023-11-06 |
프리트 엠. 쇼드하리 |
다양한 면역세포를 위한 단일사슬 및 다중사슬 합성 항원 수용체
|
|
WO2022234158A1
(es)
*
|
2021-05-06 |
2022-11-10 |
Institut D'investigacions Biomèdiques August Pi I Sunyer (Idibaps) |
Terapia de células t con receptor de antígeno quimérico específico de cd19
|
|
WO2022266075A1
(en)
|
2021-06-14 |
2022-12-22 |
Caribou Biosciences, Inc. |
Methods and materials for treating cancer using car constructs with an intracellular domain comprising a stap domain and a kinase domain or a stap domain and a phosphatase domain
|
|
CN118891374A
(zh)
|
2022-03-24 |
2024-11-01 |
南京传奇生物科技有限公司 |
制备dna文库和检测逆转录病毒整合位点的方法
|
|
WO2025051339A1
(en)
|
2023-09-05 |
2025-03-13 |
Tiber Biotech Srl |
SINGLE-CHAIN VARIABLE FRAGMENT AND MOLECULES DERIVING THEREFROM THAT BIND FRAGMENT TRVB5-1 OF THE β CHAIN OF HUMAN T-CELL RECEPTOR
|
|
EP4574838A1
(en)
|
2023-12-21 |
2025-06-25 |
Vilnius University |
Chimeric antigen receptor (car) with enhanced recruitment of signaling partners
|